Cutaneous administration system
AssigneeHewlett-Packard Development Company, L.P.
InventorsRay L. Pickup, Clement C. Lo, William D. Noonan
Life of this patent
Estimating the term…
Loading patent…
AssigneeHewlett-Packard Development Company, L.P.
InventorsRay L. Pickup, Clement C. Lo, William D. Noonan
Estimating the term…
Bioactive agents are cutaneously delivered by a jet dispenser using inkjet technology, such as that used in printing. The dispenser propels precise volumes of bioactive agent toward the skin, where they exert a local or topical effect, or move through the skin for transdermal systemic delivery. Drugs are either delivered directly to the skin, or are introduced into a transdermal patch, which may receive repeated dosages. A controller in the dispenser may control delivery of multiple different drugs, timing of drug administration, or change drug regimens in response to a changing medical condition of a patient, such as those monitored by a sensor in communication with the controller, for example to prevent an overdose. The dispenser may act as an electromechanical patch, capable of long term administration of drugs to the skin, to achieve local or systemic pharmaceutical effects. Administration methods are also provided, along with replacement kits.
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator according to claim wherein the dermal patch is of an absorbent material which receives said delivery of said composition.
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target comprising skin covering a subject having a measurable parameter, the applicator comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bio active composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bio active composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
An applicator for cutaneous delivery of a bioactive composition to a cutaneous target, comprising:
Dependencies are inferred from the claim text.